Vanda Pharmaceuticals Inc
VNDAHealthcare|Biotechnology|USA
$6.24
-0.14 (-2.19%)
DCF (FCF)
$3.02
Tangible Book
$2.76
Earnings Power
$1.56
About
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Stock Price
+25.1%(1Y)
Pipeline Summary
85 total trials22
Phase 1
26
Phase 2
32
Phase 3
3
Phase 4
Completed: 54Recruiting: 15ENROLLING_BY_INVITATION: 1Active: 3Terminated: 5Unknown: 4Withdrawn: 1NOT_YET_RECRUITING: 1AVAILABLE: 1
Active Trials (18)
Randomized Withdrawal Study in Patients With Schizophrenia
NCT06961968Schizophrenia
Phase 3Recruiting
Enrollment: 400 participants
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
NCT06138613Motion Sickness
Phase 3Active
Enrollment: 705 participants
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
NCT06701396Sleep Wake Disorders
Phase 3Recruiting
Enrollment: 60 participants
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
NCT07065773Onychomycosis of Toenail
Phase 2Active
Enrollment: 50 participants
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
NCT07446439Nausea and Vomiting
Phase 3Recruiting
Enrollment: 280 participants
BioScore
4.6/10
Cautious
Ownership
Recent News
2026-07-10 21:00:05
2026-07-07 21:25:52
2026-07-07 21:00:07
Data last updated: Jul 12, 2026, 07:36 PM